Erica Schwartz's CDC Nomination Shifts Focus Away from Controversial Vaccine Policies

U.S. Health Secretary Robert F. Kennedy Jr. announced to senators on Wednesday that if confirmed, Erica Schwartz will independently make decisions as the incoming CDC director.

This nomination indicates a strategic shift from Kennedy's controversial vaccine policies, as the administration turns to popular issues like drug price reduction.

Schwartz, deputy surgeon general during COVID-19, is seen as a traditional choice. The decision comes amid lingering tensions over past vaccine policy disagreements at the CDC.

(With inputs from agencies.)